F
Freddie Bray
Researcher at International Agency for Research on Cancer
Publications - 452
Citations - 345102
Freddie Bray is an academic researcher from International Agency for Research on Cancer. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 111, co-authored 402 publications receiving 262938 citations. Previous affiliations of Freddie Bray include University of Oslo.
Papers
More filters
Journal ArticleDOI
Cancer registration for cancer control in Latin America: a status and progress report
TL;DR: Key elements for improving cancer surveillance in the region are outlined, including 1) involvement of local stakeholders and experts, 2) integration of cancer registries into existing surveillance systems, 3) improvement in data availability and quality, 4) enhanced communication and dissemination, and 5) better linkages between cancer Registries and cancer planning and cancer research.
Journal ArticleDOI
The world cancer patient population (WCPP): An updated standard for international comparisons of population-based survival.
Adalberto Miranda-Filho,Freddie Bray,Hadrien Charvat,Swaminathan Rajaraman,Isabelle Soerjomataram +4 more
TL;DR: An update of a global standard for cancer survival comparisons entitled the World Cancer Patient Population (WCPP), constructed from the current global age distributions of cancer patients, is proposed.
Journal ArticleDOI
The risk of cancer attributable to diagnostic medical radiation: Estimation for France in 2015.
Claire Marant-Micallef,Kevin D. Shield,Jérôme Vignat,Enora Clero,Ausrele Kesminiene,Catherine Hill,Agnès Rogel,Blandine Vacquier,Freddie Bray,Dominique Laurier,Isabelle Soerjomataram +10 more
TL;DR: The contribution of medical IR to the cancer burden is small, and the benefits largely outweigh its harms, however, some of these IR‐associated cancer cases may be preventable through dose optimization of and enhanced justification for diagnostic examinations.
Journal ArticleDOI
Quantitative evaluation of hepatitis B virus mutations and hepatocellular carcinoma risk: a meta-analysis of prospective studies.
TL;DR: This study demonstrated that PreS mutations, C1653T, T1753V, and A1762T/G1764A, were associated with an increased risk of HCC.
Journal ArticleDOI
Regional trends in prostate cancer incidence, treatment with curative intent and mortality in Norway 1980-2007.
Rune Kvåle,Bjørn Møller,Anders Angelsen,Olav Dahl,Sophie D. Fosså,Ole J. Halvorsen,L. Hoem,Arne Solberg,Rolf Wahlqvist,Freddie Bray +9 more
TL;DR: The elucidation of the prostate cancer mortality trends is hindered by an inability to tease out the potential effects of early treatment from the more general impact of improved and more active treatment, and it is likely that both sets of intervention have contributed to the decline in prostate cancer deaths in Norway.